Invesco Biotechnology & Genome ETF Rating $62.63 +0.96 (+1.56%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$62.75 +0.12 (+0.19%) As of 05/2/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.69Holdings in PBE have an aggregate rating of Moderate Buy based on 433 analyst ratings issued in the past year covering 30 companies (99.8% of the portfolio).PBE Aggregate Price Target$62.63High Prediction$62.63Average Prediction$62.63Low Prediction$62.63Holdings in PBE have an aggregate price target of $62.63 and a range of $62.63 to $62.63 covering 30 companies (99.8% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.39%NTRANatera$156.66+3.5%2.8908 of 5 stars3.00$175.76 12.2%16Upcoming EarningsInsider Trade5.33%GILDGilead Sciences$103.68+0.4%4.7881 of 5 stars2.78$110.55 6.6%27Dividend Announcement5.23%AMGNAmgen$281.22-0.9%4.0928 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap Up4.64%BIIBBiogen$123.53+2.2%4.704 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage4.59%NBIXNeurocrine Biosciences$109.68+2.9%4.8844 of 5 stars2.86$160.90 46.7%22Upcoming Earnings4.58%UTHRUnited Therapeutics$294.60+0.3%4.9871 of 5 stars2.67$392.00 33.1%12Earnings ReportAnalyst ForecastInsider TradePositive News4.43%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8363 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume4.37%ILMNIllumina$77.88+1.8%4.7104 of 5 stars2.48$137.55 76.6%21Upcoming EarningsAnalyst ForecastNews CoveragePositive News3.94%TGTXTG Therapeutics$43.44-4.3%3.3281 of 5 stars2.80$40.80 -6.1%5Upcoming EarningsNews CoveragePositive News3.73%PTGXProtagonist Therapeutics$45.51+1.2%3.5021 of 5 stars3.00$65.44 43.8%9Upcoming EarningsNews CoveragePositive News3.30%CPRXCatalyst Pharmaceuticals$24.84+2.3%4.704 of 5 stars3.13$32.29 30.0%8Upcoming EarningsPositive News3.23%QGENQiagen$43.15+2.3%3.8175 of 5 stars2.30$48.42 12.2%10Upcoming EarningsNews CoverageGap Up3.18%HALOHalozyme Therapeutics$61.19+1.9%4.1264 of 5 stars2.60$62.89 2.8%10Upcoming EarningsAnalyst RevisionNews Coverage2.98%EXELExelixis$39.60+1.8%3.9984 of 5 stars2.47$37.59 -5.1%19Short Interest ↑Analyst RevisionNews CoveragePositive News2.96%RPRXRoyalty Pharma$32.89+1.3%4.2909 of 5 stars3.00$42.50 29.2%5Upcoming EarningsPositive News2.89%VCYTVeracyte$30.35+2.2%4.0398 of 5 stars2.70$42.60 40.4%10Upcoming EarningsShort Interest ↑Positive NewsHigh Trading Volume2.82%CDNACareDx$15.00-0.5%3.6659 of 5 stars2.57$30.33 102.2%7Earnings ReportInsider TradePositive NewsGap Up2.81%BPMCBlueprint Medicines$104.64+5.4%1.7629 of 5 stars2.76$127.22 21.6%21Earnings ReportAnalyst ForecastNews Coverage2.79%EXASExact Sciences$51.55+9.3%4.5145 of 5 stars2.95$70.90 37.5%22Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap UpHigh Trading Volume2.74%COLLCollegium Pharmaceutical$27.65+2.2%3.9808 of 5 stars2.80$43.60 57.7%5Upcoming EarningsNews CoveragePositive News2.63%MNKDMannKind$5.00+1.0%3.1494 of 5 stars3.22$9.56 91.3%9Upcoming EarningsNews CoveragePositive News2.62%DVAXDynavax Technologies$11.33-1.3%4.3816 of 5 stars2.33$20.50 80.9%3Upcoming EarningsNews Coverage2.56%PTCTPTC Therapeutics$49.95+0.9%3.9325 of 5 stars2.53$63.92 28.0%15Upcoming EarningsAnalyst RevisionNews CoveragePositive News2.53%BMRNBioMarin Pharmaceutical$62.03-1.1%4.9217 of 5 stars2.70$92.95 49.9%23Analyst ForecastAnalyst RevisionNews CoverageGap Up2.47%BCRXBioCryst Pharmaceuticals$8.93+2.5%4.4999 of 5 stars2.88$16.13 80.6%8Upcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage2.45%TECHBio-Techne$50.49+1.7%4.8901 of 5 stars2.38$81.14 60.7%8Upcoming EarningsPositive NewsGap Up2.37%INCYIncyte$62.53+0.8%4.7859 of 5 stars2.17$73.53 17.6%18Earnings ReportAnalyst ForecastAnalyst RevisionPositive News2.37%ACADACADIA Pharmaceuticals$14.91+2.3%4.2517 of 5 stars2.50$23.87 60.1%16Upcoming EarningsAnalyst Revision2.16%MYGNMyriad Genetics$7.56+6.0%4.0188 of 5 stars2.19$20.61 172.6%16Upcoming EarningsHigh Trading Volume1.75%XNCRXencor$11.26+3.7%3.2435 of 5 stars3.13$32.86 191.8%8Upcoming EarningsAnalyst Forecast This page (NYSEARCA:PBE) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBE Stock Free PBE Stock Alerts